CPRX logo

Catalyst Pharmaceuticals, Inc. (CPRX) EV/EBITDA

EV/EBITDA:

6.39-0.03(-0.47%)
September 9, 2025

Summary

  • As of today (September 10, 2025), CPRX EV/EBITDA is 6.39, with a fall of -0.03 (-0.47%) during the most recent trading session on September 9, 2025.
  • Over the past year, CPRX EV/EBITDA has dropped by -9.59 (-60.01%).
  • CPRX EV/EBITDA is now -88.75% below its all-time high of 56.79.

Performance

CPRX EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

OtherCPRXvaluation metrics

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

CPRX EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday-0.5%-0.5%-0.4%
1 m1 month+0.9%+1.0%+0.7%
3 m3 months-33.2%-30.1%-22.6%
6 m6 months-30.8%-16.5%-8.9%
ytdytd-25.8%-10.5%-4.2%
1 y1 year-60.0%-8.3%+1.8%
5 y5 years+30.9%+743.6%+530.9%

CPRX EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month6.86-6.8%6.25+2.2%
3 m3-month9.77-34.6%6.23+2.6%
6 m6-month11.20-43.0%6.23+2.6%
1 y1-year17.62-63.7%6.23+2.6%
3 y3-year20.98-69.5%6.23+2.6%
5 y5-year20.98-69.5%4.34+47.2%
alltimeall time56.79-88.8%-54.25+111.8%

CPRX EV/EBITDA History

DateValue
2025
6.39(-25.8%)
2024
8.61(-38.1%)
2023
13.90(-13.7%)
2022
16.10(+66.8%)
2021
9.65(+97.3%)
2020
4.89(-46.9%)
2019
9.21(-325.7%)
2018
-4.08(-76.0%)
2017
-17.01(+600.0%)
DateValue
2016
-2.43(-65.8%)
2015
-7.10(-37.7%)
2014
-11.40(+43.4%)
2013
-7.95(+1372.2%)
2012
-0.54(-87.4%)
2011
-4.28(+39.9%)
2010
-3.06(+524.5%)
2009
-0.49(-60.8%)
2008
-1.25(-77.0%)
2007
-5.44

FAQ

  • What is Catalyst Pharmaceuticals, Inc. EV/EBITDA?
  • What is the all time high EV/EBITDA for Catalyst Pharmaceuticals, Inc.?
  • What is CPRX EV/EBITDA year-to-date change?
  • What is Catalyst Pharmaceuticals, Inc. EV/EBITDA year-on-year change?

What is Catalyst Pharmaceuticals, Inc. EV/EBITDA?

The current EV/EBITDA of CPRX is 6.39

What is the all time high EV/EBITDA for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high EV/EBITDA is 56.79

What is CPRX EV/EBITDA year-to-date change?

Catalyst Pharmaceuticals, Inc. EV/EBITDA has changed by -2.22 (-25.78%) since the beginning of the year

What is Catalyst Pharmaceuticals, Inc. EV/EBITDA year-on-year change?

Over the past year, CPRX EV/EBITDA has changed by -9.59 (-60.01%)
On this page